We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
In 2011, the US FDA issued an advisory regarding the potential formation of glass lamellae in vials containing injectable drugs. This was in response to several drug recalls in 2010-11. The number of glass-related drug recalls has since declined greatly. This no doubt is due to key actions taken by pharmaceutical manufacturers before the drug goes to market, even during the development phases.
These actions are better risk assessments and more comprehensive/proactive evaluations of drug formulation interactions with container closure systems. Such actions are especially encouraged as the glass delamination phenomenon may take months, or even years, to occur. Evaluating only during manufacturing is ineffective, and risks not only recalls, but patient safety.
At West, we highly recommend this proactive approach. And to enable customers in using it, we have gathered our expertise in container and delivery systems into comprehensive, customizable Integrated Solutions proposal packages. These comprise relevant testing for any phase of the drug development process, and across all systems, whether based on glass or polymer (e.g., Daikyo Crystal Zenith® cyclic olefin polymer).
With the growing need to store at cryogenic temperatures (gene and cell therapies), and use silicon-free components, polymer components are often preferred to those of glass. The Integrated Solutions approach enables customers to make the right choices. For more, please contact a West Technical Customer Service (TCS) representative or visit our Daikyo Crystal Zenith cyclic olefin polymer vials page and the Integrated Solutions page.
This year, West Singapore partnered with Community Chest and the Care Corner Family Centre.
Have you thought about the complexities of a patient’s journey through treatment? Navigating from leukemia diagnosis to treatment can be a difficult one. Informing family members, managing loved ones’ reactions, weighing the many different treatment options and facing the reality of multiple hospital visits can be overwhelming.
West and Dublin City University (DCU) in Ireland have formed a 4-year educational partnership that will provide 180 students from socio-economically disadvantaged backgrounds with scholarships and educational opportunities. The partnership with the DCU Access programme features the creation of a new annual €45,000 scholarship fund by West to run for four years.
On May 30, 2015, West employees in Germany donated their time and manpower to support two local non-profit organizations—<a href="http://www.pferde-staerken-online.de/"><span style="text-decoration: underline;">Kids auf Trab</span></a> and <a href="http://zwischenuns-filzbluete.de/?page_id=371"><span style="text-decoration: underline;">Zwischen Uns e.V.</span></a>—with a community day, held under the patronage of Rudi Bertram, mayor of Eschweiler.
West’s Global 2016 Internship Program has, once again, quickly come to a close. This year a group of over 40 interns, chosen from a pool of 1,156 applicants, provided a wealth of knowledge, new perspectives, and unique strengths and skill sets to the business. Interns were placed at our West locations around the globe.
English
Chinese
